The Cost and Cost-Effectiveness of Scaling up Screening and Treatment of Syphilis in Pregnancy: A Model
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Syphilis in pregnancy imposes a significant global health and economic burden. More than half of cases result in serious adverse events, including infant mortality and infection. The annual global burden from mother-to-child transmission (MTCT) of syphilis is estimated at 3.6 million disability-adjusted life years (DALYs) and $309 million in medical costs. Syphilis screening and treatment is simple, effective, and affordable, yet, worldwide, most pregnant women do not receive these services. We assessed cost-effectiveness of scaling-up syphilis screening and treatment in existing antenatal care (ANC) programs in various programmatic, epidemiologic, and economic contexts. METHODS AND FINDINGS: We modeled the cost, health impact, and cost-effectiveness of expanded syphilis screening and treatment in ANC, compared to current services, for 1,000,000 pregnancies per year over four years. We defined eight generic country scenarios by systematically varying three factors: current maternal syphilis testing and treatment coverage, syphilis prevalence in pregnant women, and the cost of healthcare. We calculated program and net costs, DALYs averted, and net costs per DALY averted over four years in each scenario. Program costs are estimated at $4,142,287 - $8,235,796 per million pregnant women (2010 USD). Net costs, adjusted for averted medical care and current services, range from net savings of $12,261,250 to net costs of $1,736,807. The program averts an estimated 5,754 - 93,484 DALYs, yielding net savings in four scenarios, and a cost per DALY averted of $24 - $111 in the four scenarios with net costs. Results were robust in sensitivity analyses. CONCLUSIONS: Eliminating MTCT of syphilis through expanded screening and treatment in ANC is likely to be highly cost-effective by WHO-defined thresholds in a wide range of settings. Countries with high prevalence, low current service coverage, and high healthcare cost would benefit most. Future analyses can be tailored to countries using local epidemiologic and programmatic data.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fleming, D. T., & Wasserheit, J. N. (1999) · Sexually Transmitted Infections · doi:10.1136/sti.75.1.3 · Cited by 2,271 · cited 1×
“Syphilis is a sexually transmitted infection, and infection with syphilis increases the risk of HIV transmission and acquisition [24,25].”
BackgroundUntreated maternal syphilis and adverse outcomes of pregnancy: a systematic review and meta-analysis
Gomez, G. B., Kamb, M. L., Newman, L. M., Mark, J., Broutet, N., & Hawkes, S. J. (2013) · Bulletin of the World Health Organization · doi:10.2471/blt.12.107623 · Cited by 634 · cited 3×
“A recent meta-analysis estimated that 52% of pregnancies among women with untreated active syphilis infection result in adverse outcomes for the infant caused by syphilis [2].”
InfluentialSelf-citationThe Estimated Direct Medical Cost of Sexually Transmitted Diseases Among American Youth, 2000
Chesson, H. W., Blandford, J. M., Gift, T. L., Tao, G., & Irwin, K. L. (2004) · Perspectives on Sexual and Reproductive Health · doi:10.1363/3601104 · Cited by 444
Self-citationSyphilis in Pregnancy in Tanzania. I. Impact of Maternal Syphilis on Outcome of Pregnancy
Watson‐Jones, D., Changalucha, J., Gumodoka, B., Weiss, H., Rusizoka, M., Ndeki, L., Whitehouse, A., Balira, R., Todd, J., Ngeleja, D., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/342952 · Cited by 261 · cited 1×
“This was based on two types of data from studies in low-income settings: the positive predictive value of a rapid test against a gold standard of laboratory based RPR and VDRL [17,18]; and the proportion of RPR positive tests with a titer of at least 1:8 [19].”
MethodBlencowe, H., Cousens, S., Kamb, M., Berman, S., & Lawn, J. E. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-s3-s9 · Cited by 236 · cited 4×
“We calculated the expected net AOs averted over four years as the product of the number of AOs in the absence of treatment and the increase in syphilis screening and treatment coverage from current to expanded services, assuming 90% treatment efficacy [9,20].”
BackgroundMethodInfluentialSelf-citationEfficacy of Treatment for Syphilis in Pregnancy
ALEXANDER, J. M., SHEFFIELD, J. S., SANCHEZ, P. J., MAYFIELD, J., & WENDEL, G. D. (1999) · Obstetrics & Gynecology · doi:10.1097/00006250-199901000-00002 · Cited by 213 · cited 3×
“We calculated the expected net AOs averted over four years as the product of the number of AOs in the absence of treatment and the increase in syphilis screening and treatment coverage from current to expanded services, assuming 90% treatment efficacy [9,20].”
BackgroundMethodHawkes, S., Matin, N., Broutet, N., & Low, N. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70104-9 · Cited by 204
Self-citationChico, R. M., Mayaud, P., Ariti, C., Mabey, D., Ronsmans, C., & Chandramohan, D. (2012) · JAMA · doi:10.1001/jama.2012.3428 · Cited by 194
Watson‐Jones, D., Gumodoka, B., Weiss, H., Changalucha, J., Todd, J., Mugeye, K., Buvé, A., Kanga, Z., Ndeki, L., Rusizoka, M., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/342951 · Cited by 172
Owusu-Edusei, K., Gift, T. L., & Ballard, R. C. (2011) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3182260987 · Cited by 63
Cited by
Thresholds for the cost–effectiveness of interventions: alternative approaches
Marseille, E., Larson, B., Kazi, D. S., Kahn, J. G., & Rosen, S. (2015) · Bulletin of the World Health Organization · doi:10.2471/blt.14.138206 · Cited by 851
Self-citationPeeling, R. W., Mabey, D., Kamb, M. L., Chen, X.-S., Radolf, J. D., & Benzaken, A. S. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.73 · Cited by 664
Self-citationKorenromp, E. L., Rowley, J., Alonso, M., Mello, M. B., Wijesooriya, N. S., Mahiané, S. G., Ishikawa, N., Le, L.-V., Newman-Owiredu, M., Nagelkerke, N., et al. (2019) · PLOS ONE · doi:10.1371/journal.pone.0211720 · Cited by 478
Self-citationThe Lancet Commission on diagnostics: transforming access to diagnostics
Fleming, K. A., Horton, S., Wilson, M. L., Atun, R., DeStigter, K., Flanigan, J., Sayed, S., Adam, P., Aguilar, B., Andronikou, S., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00673-5 · Cited by 471
Cohn, J., Owiredu, M. N., Taylor, M. M., Easterbrook, P., Lesi, O., Francoise, B., Broyles, L. N., Mushavi, A., Van Holten, J., Ngugi, C., et al. (2021) · Bulletin of the World Health Organization · doi:10.2471/blt.20.272559 · Cited by 64
Metadata
- Authors
- Kahn, J. G., Jiwani, A., Gomez, G. B., Hawkes, S. J., Chesson, H. W., Broutet, N., Kamb, M. L., & Newman, L. M.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-01-29
- Volume
- 9
- Issue
- 1
- Pages
- e87510
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2039914642
- Cited by
- 102
- References
- 10
- FWCI
- 7.00
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Cost and Cost-Effectiveness of Scaling up Screening and Treatment of Syphilis in Pregnancy: A Model. https://app.cochat.ai/papers/10.1371/journal.pone.0087510
- The paper
- Kahn, J. G., Jiwani, A., Gomez, G. B., Hawkes, S. J., Chesson, H. W., Broutet, N., Kamb, M. L., & Newman, L. M. (2014). The Cost and Cost-Effectiveness of Scaling up Screening and Treatment of Syphilis in Pregnancy: A Model. PLoS ONE. https://doi.org/10.1371/journal.pone.0087510
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.